News

Called enpatoran, the agent targets the Toll-like receptor (TLR) species 7 and 8. Some 50%-60% of patients with systemic ...
Patients with prior treatment for diabetic macular edema (DME) may require more frequent dosing of aflibercept (Eylea), ...